"Multiple sclerosis: three trials to watch" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Retinal inner layer thinning detected by OCT offers a promising biomarker for monitoring multiple sclerosis progression.

Tiziana Life Sciences is a buy due to its platform optionality and upcoming catalysts that outweigh its dilution risk and ...

The Justice Department unexpectedly dropped charges against a neuroscientist indicted for defrauding the NIH of approximately ...

Learn more about whether Biogen Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Lou Gehrig's disease, also known as amyotrophic lateral sclerosis (ALS), affects about 30,000 people in the US, and leads ...

From heart disease to neurodegeneration, Novartis makes bold deals in 2025 to expand its drug pipeline globally.

A Science study reveals how human ovaries age, explaining why female fertility declines so fast and how the biological clock accelerates in women.

In mouse models of breast cancer and melanoma, they combined this approach with an existing immunotherapy and found that it ...

Last month, “historic positive results” from uniQure’s gene therapy snapped the Huntington’s community out of years of failure. As the biotech prepares to submit for FDA approval, BioSpace looks at ...

By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for ...

Researchers have traced the earliest stages of multiple sclerosis (MS), showing that the immune system begins attacking the brain up to seven years before diagnosis.